Peder L Myhre
Peder L Myhre is an expert in Cardiology at Oslo University Hospital (Norway). As of October 2026, ScienceLeadR ranks Peder L Myhre in the top 1% of experts worldwide for Heart Failure. Peder L Myhre has authored 187 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 3 of them ongoing. SLR score: 1,104 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biochemistry - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 187
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The complexity of congestion in heart failure: a critical review of the evidence and a proposal for a multimodality approach. PMID 42895733 — hospitalization, heart failure, heart, cardiovascular diseases, tissues | Eur Heart J Qual Care Clin Outcomes | 2026 | 0 |
| Implications of Serum Transthyretin to NT-proBNP Ratio in Transthyretin Amyloid Cardiomyopathy: Insights From ATTRibute-CM. PMID 42862130 — serum, heart failure, prealbumin, amyloid, cardiomyopathies, transthyretin amyloid cardiomyopathy | JACC Heart Fail | 2026 | 0 |
| Device therapies in cardiorenal syndrome: an expert review. PMID 42611536 — heart failure, diuretics, therapeutics, cardio-renal syndrome | ESC Heart Fail | 2026 | 0 |
| Respiratory effort during sleep predicts mortality in patients with suspected obstructive sleep apnea. PMID 42371748 — mortality, sleep apnea, obstructive, respiratory tract diseases, sleep, apnea, critical care, sleep apnea syndromes, beds, physical exertion | Am J Respir Crit Care Med | 2026 | 0 |
| Prognostic relevance of β1-adrenergic receptor polymorphisms on cardiovascular outcome in patients treated with metoprolol after acute myocardial infarction - an observational study. PMID 42271119 — adrenergic agents, heterozygote, myocardial infarction, homozygote, drug therapy, receptors, adrenergic, haplotypes, pharmacology, metoprolol | Eur J Clin Pharmacol | 2026 | 0 |
Clinical Studies 16
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| EASi PROTKT A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes high blood pressure and cardiovascular disease 2025-521188-11-00 — diabetes mellitus, hypertension, safety, blood, cardiovascular diseases, blood pressure, diabetes mellitus, type 2 | Phase 3 | Recruiting | 2025 |
| Vexus Assessment and Natriuresis guided Diuretic Therapy in Acute Heart Failure NCT07558798 — hyperemia, mortality, heart failure, heart, natriuresis, diuretics, therapeutics | N/A | Not yet recruiting | 2026 |
| Management of Patients With Heart Failure at Home After Hospital Discharge NCT06576752 — monitoring, ambulatory, safety, heart failure, heart, ambulatory care facilities, outpatient clinics, hospital, maximum tolerated dose, outpatients, digital health | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map